Skip to content

Clinical trials

Phase 3 Autoimmune Diseases trials in Mexico

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Autoimmune Diseases Phase: Phase 3 Country / region: Mexico Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20081
20101
20112
20121
20132
20151
20221
20234
20242
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Active, not recruiting5
Recruiting3
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Human Genome Sciences Inc., a GSK Company4
Viatris Innovation GmbH3
Bristol-Myers Squibb2
Anthera Pharmaceuticals1
AstraZeneca1
Baxalta now part of Shire1
Eli Lilly and Company1
GlaxoSmithKline1
Human Genome Sciences Inc.1
Immunovant Sciences GmbH1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Autoimmune Diseases19
Lupus Erythematosus, Systemic12
Immune System Diseases10
Connective Tissue Diseases7
Glomerulonephritis2
Kidney Diseases2
Lung Diseases, Interstitial2
Lupus Nephritis2
Nephritis2
Arthritis, Rheumatoid1

Trials

Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.